AZIYO BIOLOGICS, INC. Contracts & Agreements
73 Contracts & Agreements
- Business Finance (43 contracts)
- Business Operations (5)
- Human Resources (14)
- Intellectual Property (2)
- Uncategorized (9)
- Form of Prefunded Warrant (Filed With SEC on June 18, 2024)
- Placement Agency Agreement (Filed With SEC on June 18, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on June 18, 2024)
- Second Amendment to Credit Agreement, dated March 27, 2024, by and among Elutia Inc., SWK Funding LLC, as Agent, and the Lenders from time to time party thereto (Filed With SEC on April 1, 2024)
- Form of Amendment to Stock Option Agreements, dated January 31, 2024, between the Company and C. Randal Mills, Ph.D (Filed With SEC on February 2, 2024)
- Form of Amendment to Restricted Stock Unit Agreements, dated January 31, 2024, between the Company and C. Randal Mills, Ph.D (Filed With SEC on February 2, 2024)
- Form of Stock Option Agreement under the Aziyo Biologics, Inc. Amended and Restated 2020 Incentive Award Plan (Filed With SEC on February 2, 2024)
- Form of Restricted Stock Unit Agreement under the Aziyo Biologics, Inc. Amended and Restated 2020 Incentive Award Plan (Filed With SEC on February 2, 2024)
- Amendment No. 1 to Royalty Agreement, dated January 10, 2024 (Filed With SEC on January 12, 2024)
- Amendment Letter, dated November 8, 2023, by and between Elutia Inc. and SWK Funding LLC (Filed With SEC on November 15, 2023)
- Contract Manufacturing Agreement, dated November 8, 2023, by and between Elutia Inc. and Berkeley Biologics, LLC (Filed With SEC on November 15, 2023)
- Form of Common Warrant (Filed With SEC on September 21, 2023)
- Form of Prefunded Warrant (Filed With SEC on September 21, 2023)
- Securities Purchase Agreement, dated September 18, 2023, by and among Elutia Inc. and the Investors named therein (Filed With SEC on September 21, 2023)
- Registration Rights Agreement, dated September 21, 2023, by and among Elutia Inc. and the Investors named therein (Filed With SEC on September 21, 2023)
- Asset Purchase Agreement, dated September 17, 2023, by and among Elutia Inc., Berkeley Biologics, LLC, and GNI Group, Ltd. (solely with respect to Section 11.18) (Filed With SEC on September 19, 2023)
- Distribution Agreement by and between Aziyo Biologics, Inc. and LeMaitre Vascular, Inc (Filed With SEC on August 14, 2023)
- First Amendment, dated as of May 12, 2023, to the Credit Agreement, dated August 10, 2022, by and among Aziyo Biologics, Inc., SWK Funding LLC, as Agent and the Lenders from time... (Filed With SEC on May 12, 2023)
- Aziyo Biologics, Inc. 2020 Incentive Award Plan and form of stock option agreements thereunder (Filed With SEC on March 23, 2023)
- Form of Restricted Stock Unit Award Agreement (approved October 2020) (Filed With SEC on March 23, 2023)
- Letter Agreement, dated as of March 22, 2023, by and between Aziyo Biologics, Inc. and Thomas Englese (Filed With SEC on March 23, 2023)
- Amended and Restated Employment Agreement, dated December 23, 2022, by and between Aziyo Biologics, Inc. and Matthew Ferguson (Filed With SEC on December 30, 2022)
- Amended and Restated Employment Agreement, dated December 23, 2022, by and between Aziyo Biologics, Inc. and Thomas Englese (Filed With SEC on December 30, 2022)
- Underwriting Agreement, dated December 1, 2022, by and between Aziyo Biologics, Inc. and Cantor Fitzgerald & Co (Filed With SEC on December 5, 2022)
- Amendment Letter, dated as of November 30, 2022, to the Credit Agreement, dated as of August 10, 2022, among Aziyo Biologics, Inc., SWK Funding LLC, as Agent, and the Lenders from... (Filed With SEC on December 5, 2022)
- Amendment Letter, dated as of November 21, 2022, to the Credit Agreement, dated as of August 10, 2022, among Aziyo Biologics, Inc., SWK Funding LLC, as Agent, and the Lenders from... (Filed With SEC on November 28, 2022)
- Amendment Letter, dated as of November 10, 2022 to Credit Agreement, dated as of August 10, 2022, between Aziyo Biologics, Inc. and SWK Funding LLC, as Agent and the Lenders from... (Filed With SEC on November 14, 2022)
- Form of Restricted Stock Unit Award Agreement (approved August 2022) (Filed With SEC on November 14, 2022)
- Amendment Letter to Credit Agreement, dated as of October 9, 2022, between Aziyo Biologics, Inc. and SWK Funding LLC, as Agent and a Lender (Filed With SEC on October 13, 2022)
- Warrant to Purchase Stock, issued on August 10, 2022, by Aziyo Biologics, Inc.to SWK Funding LLC (Filed With SEC on August 15, 2022)
- Credit Agreement, dated as of August 10, 2022, between Aziyo Biologics, Inc. and the subsidiaries of the Company, with the financial institutions party thereto from time to time... (Filed With SEC on August 15, 2022)
- Separation and Release of Claims Agreement, dated June 21, 2022, by and between Ronald Lloyd and Aziyo Biologics, Inc (Filed With SEC on June 21, 2022)
- Employment Agreement, dated June 21, 2022, by and between C. Randal Mills, Ph.D. and Aziyo Biologics, Inc (Filed With SEC on June 21, 2022)
- Second Amendment, dated January 21, 2022, to Amended and Restated Credit and Security Agreement (Revolving Loan), dated as of July 15, 2019, by and among the Registrant and Aziyo... (Filed With SEC on March 8, 2022)
- Second Amendment, dated January 21, 2022, to Amended and Restated Credit and Security Agreement (Term Loan), dated as of July 15, 2019, by and among the Registrant and Aziyo Med,... (Filed With SEC on March 8, 2022)
- Securities Purchase Agreement, dated December 5, 2021, by and among Aziyo Biologics, Inc. and the Investors named therein (Filed With SEC on December 8, 2021)
- Registration Rights Agreement, dated December 5, 2021, by and among Aziyo Biologics, Inc. and the Investors named therein (Filed With SEC on December 8, 2021)
- Description of Securities (Filed With SEC on March 15, 2021)
- Form of Underwriting Agreement (Filed With SEC on September 30, 2020)
- Specimen stock certificate evidencing the shares of Class B common stock (Filed With SEC on September 30, 2020)
- Aziyo Biologics, Inc. 2020 Incentive Award Plan and form of award agreements thereunder (Filed With SEC on September 30, 2020)
- Aziyo Biologics, Inc. Non-Employee Director Compensation Program (Filed With SEC on September 30, 2020)
- Aziyo Biologics, Inc. 2020 Employee Stock Purchase Plan (Filed With SEC on September 30, 2020)
- Amended and Restated Employment Agreement, by and between the Registrant and Ronald Lloyd, dated as of September 30, 2020 (Filed With SEC on September 30, 2020)
- Employment Agreement, by and between the Registrant and Thomas Englese, dated as of September 30, 2020 (Filed With SEC on September 30, 2020)
- Employment Agreement, by and between the Registrant and Darryl Roberts, dated as of September 30, 2020 (Filed With SEC on September 30, 2020)
- Employment Agreement, by and between the Registrant and Matthew Ferguson, dated as of September 30, 2020 (Filed With SEC on September 30, 2020)
- Form of Indemnification Agreement for Directors and Officers (Filed With SEC on September 30, 2020)
- Amended and Restated Credit and Security Agreement (Term Loan), dated as of July 15, 2019, by and among the Registrant and Aziyo Med, LLC, as Borrowers, Midcap Financial Trust, as... (Filed With SEC on September 30, 2020)
- Amended and Restated Credit and Security Agreement (Revolving Loan), dated as of July 15, 2019, by and among the Registrant and Aziyo Med, LLC, as Borrowers, Midcap Funding IV... (Filed With SEC on September 30, 2020)
- Second Amended and Restated Investor Rights Agreement, dated as of September 14, 2020, among the Registrant and the investors named therein (Filed With SEC on September 14, 2020)
- Specimen stock certificate evidencing the shares of Class A common stock (Filed With SEC on September 14, 2020)
- Warrant to Purchase Shares of Common Stock, dated as of March 27, 2017, issued by the Registrant to HighCape Partners QP, L.P (Filed With SEC on September 14, 2020)
- Warrant to Purchase Shares of Series A Convertible Preferred Stock, dated as of May 31, 2017, issued by the Registrant to Flexpoint MCLS Holdings LLC (Filed With SEC on September 14, 2020)
- Warrant to Purchase Shares of Series A Convertible Preferred Stock, dated as of May 31, 2017, issued by the Registrant to MidCap Funding XXVII Trust (Filed With SEC on September 14, 2020)
- Warrant to Purchase Shares of Series A Convertible Preferred Stock, dated as of December 14, 2017, issued by the Registrant to Flexpoint MCLS Holdings LLC (Filed With SEC on September 14, 2020)
- Warrant to Purchase Shares of Series A Convertible Preferred Stock, dated as of December 14, 2017, issued by the Registrant to MidCap Funding XXVII Trust (Filed With SEC on September 14, 2020)
- 2015 Stock Option/Stock Issuance Plan, as amended, and form of option agreements thereunder (Filed With SEC on September 14, 2020)
- Employment Agreement, by and between the Registrant and Ronald Lloyd, dated as of June 1, 2018 (Filed With SEC on September 14, 2020)
- Letter Agreement, by and between the Registrant and Thomas Englese, dated as of June 25, 2019 (Filed With SEC on September 14, 2020)
- Letter Agreement, by and between the Registrant and Darryl Roberts, dated as of April 2, 2018 (Filed With SEC on September 14, 2020)
- Letter Agreement, by and between the Registrant and Jerome Riebman (Filed With SEC on September 14, 2020)
- Letter Agreement, by and between the Registrant and Jeffrey Hamet (Filed With SEC on September 14, 2020)
- Amended and Restated Credit and Security Agreement (Term Loan), dated as of July 15, 2019, by and among the Registrant and Aziyo Med, LLC, as Borrowers, Midcap Financial Trust, as... (Filed With SEC on September 14, 2020)
- Amended and Restated Credit and Security Agreement (Revolving Loan), dated as of July 15, 2019, by and among the Registrant and Aziyo Med, LLC, as Borrowers, Midcap Funding IV... (Filed With SEC on September 14, 2020)
- Note Purchase Agreement, dated as of April 2, 2020, by and between the Registrant and each of the persons and entities set forth on Schedule A thereto (Filed With SEC on September 14, 2020)
- Amendment to Note Purchase Agreement, dated as of April 29, 2020, by and between the Registrant and each of the persons and entities signatory thereto (Filed With SEC on September 14, 2020)
- U.S. Small Business Administration Paycheck Protection Program Note, dated as of May 7, 2020, by and between the Registrant and Silicon Valley Bank (Filed With SEC on September 14, 2020)
- Royalty Agreement, dated as of May 31, 2017, by and between Aziyo Med, LLC and Ligand Pharmaceuticals Incorporated (Filed With SEC on September 14, 2020)
- License Agreement, dated as of May 31, 2017, by and between Cook Biotech Incorporated and Aziyo Med, LLC (Filed With SEC on September 14, 2020)
- December 2017 Amendment to License Agreement, dated as of December 21, 2017, by and between Cook Biotech Incorporated and Aziyo Med, LLC (Filed With SEC on September 14, 2020)
- Letter Agreement, dated as of May 31, 2017, by and between HighCape Partners Management, L.P. and the Registrant (Filed With SEC on September 14, 2020)
- Settlement Agreement and General Release, by and between the Registrant and KeraLink International Inc. (formerly named Tissue Banks International, Inc.), dated as of April 6, 2018 (Filed With SEC on September 14, 2020)
